First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced Cancer
Shapiro, Geoffrey I, Bell-McGuinn, Katherine M, Molina, Julian R, Bendell, Johanna, Spicer, James, Kwak, Eunice L, Pandya, Susan S, Millham, Robert, Borzillo, Gary, Pierce, Kristen J, Han, Lixin, Houk, Brett E, Gallo, Jorge D, Alsina, Maria, Braña, Irene, Tabernero, Josep
Published in Clinical cancer research (15.04.2015)
Published in Clinical cancer research (15.04.2015)
Get full text
Journal Article
Association of programmed death ligand‐1 (PD‐L1) expression with treatment outcomes in patients with BRAF mutation‐positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenib
Wongchenko, Matthew J., Ribas, Antoni, Dréno, Brigitte, Ascierto, Paolo A., McArthur, Grant A., Gallo, Jorge D., Rooney, Isabelle A., Hsu, Jessie, Koeppen, Hartmut, Yan, Yibing, Larkin, James
Published in Pigment cell and melanoma research (01.07.2018)
Published in Pigment cell and melanoma research (01.07.2018)
Get full text
Journal Article
Predictive Biomarkers of Response to Venetoclax in Combination with Cobimetinib in Relapsed/Refractory Multiple Myeloma (RRMM)
Raval, Aparna, Hamidi, Habib, Hwang, Olivia, Green, Cherie, Maia, Catarina, Lasa, Marta, Onishi, Maika, Rodriguez-Otero, Paula, San-Miguel, Jesús F., Gallo, Jorge D., Paiva, Bruno, Schjesvold, Fredrik
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Safety and Preliminary Efficacy Results from a Phase Ib/II Study of Cobimetinib As a Single Agent and in Combination with Venetoclax with or without Atezolizumab in Patients with Relapsed/Refractory Multiple Myeloma
Schjesvold, Fredrik, Ribrag, Vincent, Rodriguez-Otero, Paula, Robak, Pawel J., Hansson, Markus, Hajek, Roman, Amor, Adrián Alegre, Martinez-López, Joaquin, Onishi, Maika, Gallo, Jorge D., Raval, Aparna, Deshpande, Sameer, Malhi, Vikram, Hong, Wan-Jen, Raab, Marc S.
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Clinical predictors of response for coBRIM: A phase III study of cobimetinib (C) in combination with vemurafenib (V) in advanced BRAF-mutated melanoma (MM)
Larkin, James M. G., McArthur, Grant A., Ribas, Antoni, Ascierto, Paolo Antonio, Gallo, Jorge D, Rooney, Isabelle Anne, Chang, Ilsung, Dréno, Brigitte
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Abstract A177: Phase 1, dose-escalation, safety, pharmacokinetic and pharmacodynamic study of single agent PF-03758309, an oral PAK inhibitor, in patients with advanced solid tumors
Rosen, Lee S., Blumenkopf, Todd A., Breazna, Aurora, Darang, Sheree, Gallo, Jorge D., Goldman, Jonathan, Wang, Diane, Mileshkin, Linda, Eckhardt, S. Gail
Published in Molecular cancer therapeutics (12.11.2011)
Published in Molecular cancer therapeutics (12.11.2011)
Get full text
Journal Article